Here we leverage a well-characterized prospective birth cohort study to investigate whether greater fecal IgA at 1 year of age directed against an immunodominant sporozoite-expressed antigen (Cp23) protects infants from subsequent cryptosporidiosis. The gene discussed is CD79A; the disease is cryptosporidiosis.